Concepedia
Statistics
Publications
43
Citations
3K
H-Index
25
Active since
2010
Affiliations
EsSALUD(Current)
Instituto Nacional de Enfermedades Neoplásicas
Universidad Privada San Juan Bautista
Vanderbilt University
Universidad Científica del Sur
Joseph A. Pinto is an author at EsSALUD specializing in oncology, medicine, and molecular oncology.
Publications per year
2010–2023
Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
Justin M. Balko, Jennifer M. Giltnane, Kai Wang et al. · Cancer Discovery · 2013 · 477 citations · Full text
Medicine, Cancer Biology, Oncology +17
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
James Glasbey, Adesoji Ademuyiwa, Adewale Adisa et al. · The Lancet Oncology · 2021 · 289 citations · Full text
Medicine, Oncology, Surgery +11
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance
Justin M. Balko, Rebecca S. Cook, David Vaught et al. · Nature Medicine · 2012 · 262 citations · Full text
Medicine, Cancer Biology, Oncology +16
Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
James Glasbey, Dmitri Nepogodiev, Joana Simões et al. · Journal of Clinical Oncology · 2020 · 222 citations · Full text
Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
Joseph A. Pinto, Carlos Vallejos, Luis E. Raez et al. · ESMO Open · 2018 · 168 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 43